Results 131 to 140 of about 261,869 (302)

Influenza‐Associated Encephalopathy

open access: yes
Annals of the Child Neurology Society, EarlyView.
Andrew Silverman, Chrisoula Cheronis
wiley   +1 more source

Take time to get a flu vaccine [PDF]

open access: yes
For the 2017-2018 season, CDC recommends an injectable flu shot (inactivated influenza vaccine or recombinant influenza vaccine). The nasal spray flu vaccine (live attenuated influenza vaccine or LAIV) should not be used during 2017-2018.CS HCVG-15-FLU ...

core  

Cancer in pregnancy: FIGO Best practice advice and narrative review

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Cancer during pregnancy is relatively rare. The incidence is underestimated due to the lack of international registries covering both high‐income and low‐ and middle‐income countries, and is expected to rise with increasing maternal age and increasing global adoption of cell‐free DNA testing for aneuploidy.
Surabhi Nanda   +29 more
wiley   +1 more source

Response to influenza vaccine in adjuvant 65-4 [PDF]

open access: bronze, 1975
J. W. G. Smith   +4 more
openalex   +1 more source

The impact of the COVID‐19 pandemic on the diagnosis and management of pre‐eclampsia: Identifying healthcare delays

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare the prevalence of pre‐eclampsia with and without severe features, and maternal and perinatal outcomes before and during the COVID‐19 pandemic. Methods Cross‐sectional study based on medical chart review of pregnant women admitted to a referral maternity hospital for childbirth between September 2019 to February 2020 ...
Juliana da‐Costa‐Santos   +12 more
wiley   +1 more source

Enhanced Immunogenicity in Mice of a Purified, Tween-Ether-Treated Influenza Vaccine [PDF]

open access: gold, 1970
James D. Fenters   +3 more
openalex   +1 more source

Recent Utilization of Pediatric Extrapolation and Modeling and Simulation Approaches in Pediatric Drug Development in Japan

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract In Japan, the percentage of approved drugs with pediatric indications increased to 30% in 2010‐2015, but no further increase was observed through 2020. The Ministry of Health, Labor, and Welfare in Japan presented draft future directions to promote pediatric drug development, where the modeling and simulation (M&S) approach was introduced as a
Akinori Nakashima   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy